Medmain

Medmain raises 3.3M USD funding to advance AI-powered digital pathology

11th May, 2025

Chris Davis

Writer

Medmain raises 3.3M USD funding to advance AI-powered digital pathology

What does Medmain do?

Medmain is a medtech startup that provides an AI-powered cloud system called PidPort to assist in digital pathology. Its technology supports remote diagnostic support, multi-facility consultations, academic and clinical conferences, and training and research across various institutions.

How much did they raise?

The company secured 3.3M USD in funding, led by One Capital with participation from Niremia Collective and Plug and Play. The funding round is classified as series_unknown and brings Medmain's total raised amount to 18M USD.

What are their plans for the money?

With the new funds, Medmain plans to enhance the development of its PidPort product, invest in digitalization infrastructure, strengthen its sales organization, apply for regulatory approval for its pathology AI, and lay the groundwork for international expansion.

What have they achieved so far?

Medmain has already made significant progress by deploying PidPort across a wide range of settings, including remote diagnostic support, consultations between medical institutions, multi-facility conferences, academic events, and educational training sessions.

Key Contacts

Osamu Lizuka
CEO

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom

© JustRaised 2025. All rights reserved.